Record:   Prev Next
Title Immunology of diabetes IV [Electronic Resource] : progress in our understanding / edited by Carani B. Sanjeevi and Toshiaki Hanafusa
Imprint Boston, Mass. : Blackwell Pub. on behalf of the New York Academy of Sciences, 2006
book jacket
Descript 1 online resource (xv, 401 p.) : ill.
Series Annals of the New York Academy of Sciences, 0077-8923 ; v. 1079
Annals of the New York Academy of Sciences ; v. 1079
Note Includes bibliographical references and index
A mini meta-analysis of studies on CD4+CD25+ T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell Workshop -- HLA class I epitope discovery in type 1 diabetes: independent and reproducible identification of proinsulin epitopes of CD8 T cells--report of the IDS T Cell Workshop Committee -- Genetics of fulminant type 1 diabetes -- Why is type 1 diabetes uncommon in Asia? -- Association of SUMO4, as a candidate gene for IDDM5, with susceptibility to type 1 diabetes in Asian populations -- The gene for human IL-21 and genetic susceptibility to type 1 diabetes in the Japanese -- Genetics of type 1 diabetes: similarities and differences between Asian and Caucasian populations -- Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults -- Genes influencing innate and acquired immunity in type 1 diabetes and latent autoimmune diabetes in adults -- Progression of autoimmune diabetes: slowly progressive insulin-dependent diabetes mellitus or latent autoimmune diabetes of adult -- Immunomodulation for the prevention of SPIDDM and LADA -- Heightened interferon-alpha/beta response causes myeloid cell dysfunction and promotes T1D pathogenesis in NOD mice -- Immunolocalization of monocyte chemoattractant protein-1 in islets of NOD mice during cyclophosphamide administration -- Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin -- Contribution of class III MHC to susceptibility to type 1 diabetes in the NOD mouse -- MHC-linked susceptibility to type 1 diabetes in the NOD mouse: further localization of Idd16 by subcongenic analysis -- Long-term prevention of diabetes and marked suppression of insulin autoantibodies and insulitis in mice lacking native insulin B9-23 sequence -- Eicosanoid imbalance in the NOD mouse is related to a dysregulation in soluble epoxide hydrolase and 15-PGDH expression -- Pancreatic autoimmunity induction with insulin B:9-23 peptide and viral mimics in the NZB mouse -- Viruses cause type 1 diabetes in animals -- Characterization of PAF-AH Ib1 in NOD mice: PAF-AH may not be a candidate gene of the diabetes susceptibility Idd4.1 locus -- Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes -- New members of the interleukin-12 family of cytokines: IL-23 and IL-27 modulate autoimmune diabetes -- Glutamic acid decarboxylase-specific CD4+ regulatory T cells -- Metabolism genes are among the differentially expressed ones observed in lymphomononuclear cells of recently diagnosed type 1 diabetes mellitus patients -- In vitro TNF-alpha and IL-6 production by adherent peripheral blood mononuclear cells obtained from type 1 and type 2 diabetic patients evaluated according to the metabolic control -- T cell immunity to glutamic acid decarboxylase in fulminant type 1 diabetes without significant elevation of serum amylase -- Expression levels of CXC chemokine receptors 3 are associated with clinical phenotype of type 1 diabetes -- HLA class I epitope discovery in type 1 diabetes -- Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis -- Normal T cell development in the absence of thymic insulin expression -- Antigenic determinants to GAD autoantibodies in patients with type 1 diabetes with and without autoimmune thyroid disease -- TSH receptor antibodies in subjects with type 1 diabetes mellitus -- Time-resolved fluorescence imaging of islet cell autoantibodies -- MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus -- Predominance of the group A killer Ig-like receptor haplotypes in Korean patients with T1D -- Frequency of CTLA-4 gene CT60 polymorphism may not be affected by vitamin D receptor gene Bsm I polymorphism or HLA DR9 in autoimmune-related type 1 diabetes in the Japanese -- Genetic and functional evidence supporting SUMO4 as a type 1 diabetes susceptibility gene -- No association of TLR2 and TLR4 polymorphisms with type I diabetes mellitus in the Basque population -- Association of SUMO4 M55V polymorphism with autoimmune diabetes in Latvian patients -- A second component of HLA-linked susceptibility to type 1 diabetes maps to class I region -- Molecular scanning of the gene for programmed cell death-1 (PDCD-1) as a candidate for type 1 diabetes susceptibility -- Genetic determinants of type 1 diabetes across populations -- TNFa-e microsatellite, HLA-DRB1 and -DQB1 alleles and haplotypes in Brazilian patients presenting recently diagnosed type 1 diabetes mellitus -- Is HLA class II profile relevant for the study of large-scale differentially expressed genes in type 1 diabetes mellitus patients? -- Feasibility of a type 1 diabetes primary prevention trial using 2000 IU vitamin D3 in infants from the general population with increased HLA-associated risk -- Interleukin-10 plasmid construction and delivery for the prevention of type 1 diabetes -- TEDDY--The Environmental Determinants of Diabetes in the Young: an observational clinical trial -- Protection from type 1 diabetes by vitamin D receptor haplotypes -- Living donor islet transplantation, the alternative approach to overcome the obstacles limiting transplant -- DiaPep277 preserves endogenous insulin production by immunomodulation in type 1 diabetes -- Cord blood islet autoantibodies are related to stress in the mother during pregnancy -- Is it dietary insulin? -- Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes--the PRODIA study -- Thiazolidinediones may not reduce diabetes incidence in type 1 diabetes -- Mechanisms mediating anti-CD3 antibody efficacy: insights from a mathematical model of type 1 diabetes -- Why diabetes incidence increases--a unifying theory -- Overcoming the challenges now limiting islet transplantation: a sequential, integrated approach
Also issued in print
Mode of access: World Wide Web
Subject Diabetes -- Immunological aspects -- Congresses
Immunogenetics -- Congresses
Diabetes Mellitus, Type 1 -- genetics -- Congresses
Diabetes Mellitus, Type 1 -- immunology -- Congresses
Diabetes Mellitus, Type 1 -- prevention & control -- Congresses
Diabetes mellitus swd
Typ 1 swd
Immunologie swd
Pathogenese swd
Autoaggressionskrankheit swd
Awaji swd
Alt Author Sanjeevi, C. B
Hanafusa, Toshiaki
New York Academy of Sciences
Alt Title Immunology of diabetes 4
Immunology of diabetes four
Record:   Prev Next